Company Analysis Thorne HealthTech, Inc.
1. Summary
Advantages
- Price (10.19 $) is less than fair price (71.11 $)
- The stock's return over the last year (0%) is higher than the sector average (-42.78%).
- The company's current efficiency (ROE=11.9%) is higher than the sector average (ROE=11.88%)
Disadvantages
- Dividends (0%) are below the sector average (2.39%).
- Current debt level 20.45% has increased over 5 years from 0%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Thorne HealthTech, Inc. | Consumer Staples | Index | |
|---|---|---|---|
| 7 days | 0% | 5.2% | 0.6% |
| 90 days | 0% | -44.7% | 8.4% |
| 1 year | 0% | -42.8% | 33.9% |
THRN vs Sector: Thorne HealthTech, Inc. has outperformed the "Consumer Staples" sector by 42.78% over the past year.
THRN vs Market: Thorne HealthTech, Inc. has significantly underperformed the market by -33.9% over the past year.
Stable price: THRN is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: THRN with weekly volatility of 0% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (10.19 $) is lower than the fair price (71.11 $).
Price significantly below the fair price: The current price (10.19 $) is 597.8% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (11.95) is lower than that of the sector as a whole (25.6).
P/E vs Market: The company's P/E (11.95) is lower than that of the market as a whole (48.12).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (1.28) is lower than that of the sector as a whole (5.75).
P/BV vs Market: The company's P/BV (1.28) is lower than that of the market as a whole (3.1).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0.8188) is lower than that of the sector as a whole (3.02).
P/S vs Market: The company's P/S indicator (0.8188) is lower than that of the market as a whole (10.15).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (19.24) is higher than that of the sector as a whole (-57.24).
EV/Ebitda vs Market: The company's EV/Ebitda (19.24) is higher than that of the market as a whole (18.05).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -38.92% over the last 5 years.
Earnings Slowdown: The last year's return (-100%) is below the 5-year average return (-38.92%).
Profitability vs Sector: The return for the last year (-100%) is lower than the return for the sector (-11.73%).
5.4. ROE
ROE vs Sector: The company's ROE (11.9%) is higher than that of the sector as a whole (11.88%).
ROE vs Market: The company's ROE (11.9%) is higher than that of the market as a whole (10.88%).
5.5. ROA
ROA vs Sector: The company's ROA (7.74%) is higher than that of the sector as a whole (6.07%).
ROA vs Market: The company's ROA (7.74%) is higher than that of the market as a whole (6.5%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (11.73%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (10.79%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '2.39%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
